S T A T E O F N E W Y O R K
________________________________________________________________________
6926
2017-2018 Regular Sessions
I N S E N A T E
October 20, 2017
___________
Introduced by Sens. HANNON, SERINO, HELMING, AMEDORE, AVELLA, BONACIC,
BOYLE, CARLUCCI, DeFRANCISCO, GOLDEN, LANZA, LARKIN, LAVALLE, LITTLE,
MARCELLINO, O'MARA, RITCHIE, TEDISCO, VALESKY, YOUNG -- read twice and
ordered printed, and when printed to be committed to the Committee on
Rules
AN ACT to amend the public health law, in relation to the diagnosis and
treatment of Lyme disease and other tick borne diseases
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Section 206-b of the public health law, as added by chapter
260 of the laws of 1988, is amended to read as follows:
§ 206-b. Special requirements with respect to Lyme disease diagnosis.
1. (A) Within thirty days after the effective date of this section, the
commissioner shall, in writing, order every physician practicing in
Suffolk, Westchester and Nassau counties to review the medical records
of any patient such physician treated during the period commencing Janu-
ary first, nineteen hundred seventy-five and ending on the date of such
order wherein such physician made a diagnosis of juvenile rheumatoid
arthritis and to review the circumstances of such diagnosis to reconsid-
er whether such patient has suffered, or is suffering, from the complex,
multi-system disorder caused by the bacterium Borrelia burgdorferi,
which disease is transmitted by the Ixodes dammini tick and is commonly
referred to as "Lyme disease". In any case where a hospital or other
health care institution or provider has custody or control of the
medical records for a patient so diagnosed, upon request such physician
shall be entitled to review such medical records for purposes of comply-
ing with such order or the commissioner may order any such hospital or
other health care institution or provider wherever situated within the
state to review such records to reconsider a diagnosis of Lyme disease.
[2.] (B) The commissioner, upon a showing that there is a reasonable
basis to believe that the order provided for [herein] IN THIS SUBDIVI-
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13579-02-7
S. 6926 2
SION has not been complied with, shall be entitled to apply to a justice
of the supreme court for an order requiring any such physician to submit
for the commissioner's consideration such records, charts or other
pertinent data which will enable him to determine whether there has been
full compliance with such order.
[3.] (C) In any case where a review of such records indicates that a
patient may have been, or is, suffering from Lyme disease, such physi-
cian shall, consistent with customary and acceptable medical standards,
take such action he OR SHE deems necessary to inform such patient or in
the case of a minor, his or her parent or guardian of his OR HER find-
ings, conduct additional tests, administer other necessary treatments or
refer such patient to another physician for further diagnosis and/or
treatment.
2. (A) THE COMMISSIONER SHALL, IN CONSULTATION WITH HEALTH CARE
PROVIDERS, RESEARCH EXPERTS, RELEVANT ADVISORY BODIES AND OTHER STAKE-
HOLDERS, DEVELOP A STANDARDIZED PROTOCOL FOR THE DIAGNOSIS AND TREATMENT
OF LYME DISEASE AND SUCH OTHER TICK BORNE DISEASES THAT MAY BE IDENTI-
FIED BY THE COMMISSIONER. SUCH PROTOCOL SHALL INCLUDE, BUT NOT BE LIMIT-
ED TO, GUIDANCE TO BE UTILIZED BY HEALTH CARE PROVIDERS WHEN A SEROLOGI-
CAL TEST COMES BACK NEGATIVE BUT SYMPTOMS OF ANY SUCH DISEASE PERSIST.
THE PROTOCOL SHALL BE UPDATED UPON ANY ADVANCEMENTS IN THE FIELD OF LYME
DISEASE, OR OTHER IDENTIFIED TICK BORNE DISEASE, TESTING AND TREATMENT.
AS PART OF THE PROTOCOL, THE COMMISSIONER SHALL DEVELOP, UPDATE AS
NECESSARY AND ENSURE PROVIDERS DISTRIBUTE TO EACH PERSON UNDER THEIR
CARE BEING TESTED FOR LYME DISEASE OR OTHER IDENTIFIED TICK BORNE
DISEASE, A STANDARDIZED NOTIFICATION FORM, WHICH SHALL EXPLAIN, IN PLAIN
NON-TECHNICAL LANGUAGE, THE FOLLOWING:
(I) THE SYMPTOMS AND RISK FACTORS FOR LYME DISEASE AND SUCH OTHER
IDENTIFIED TICK BORNE DISEASES;
(II) THE AVAILABLE METHODS FOR THE DETECTION AND DIAGNOSIS OF LYME
DISEASE AND SUCH OTHER IDENTIFIED TICK BORNE DISEASE, INCLUDING INFORMA-
TION ON THE RELATIVE ACCURACY OF THE AVAILABLE DETECTION AND DIAGNOSTIC
TECHNIQUES;
(III) THE MEDICAL PROTOCOL ADOPTED UNDER THIS SUBDIVISION; AND
(IV) RELEVANT MEDICAL INFORMATION DEEMED NECESSARY BY THE COMMISSIONER
AND SHALL CONTAIN INFORMATION ON LYME DISEASE AND SUCH OTHER IDENTIFIED
TICK BORNE DISEASES RISK, POSSIBLE CO-INFECTIONS AND OTHER PERTINENT
INFORMATION.
THE COMMISSIONER SHALL HAVE THE PROTOCOL AND STANDARDIZED NOTIFICATION
FORM, REQUIRED BY THIS SUBDIVISION, DEVELOPED AND PREPARED FOR DISTRIB-
UTION WITHIN ONE HUNDRED TWENTY DAYS OF THE EFFECTIVE DATE OF THIS
SUBDIVISION.
(B) NOTHING IN THIS SUBDIVISION SHALL BE CONSTRUED TO CREATE A CAUSE
OF ACTION FOR LACK OF INFORMED CONSENT IN ANY INSTANCE IN WHICH SUCH
CAUSE OF ACTION WOULD BE LIMITED BY SECTION TWENTY-EIGHT HUNDRED FIVE-D
OF THIS CHAPTER.
§ 2. This act shall take effect immediately.